IVD Test Reagent/Kits, Molecular Assay, Infection, Virus, Varicella-Zoster

Definition : Molecular assay reagents intended to identify varicella-zoster virus, a DNA virus of the genus Varicellavirus, family Herpesviridae, by detecting the nucleic acid of the target virus. Varicella-zoster viruses cause chickenpox (varicella), an infectious disease typically transmitted by direct contact or through the respiratory route and characterized by the appearance of vesicular lesions on the skin and mucous membranes. Activation of varicella-zoster virus from a previous chickenpox (varicella) infection may cause herpes zoster (also called shingles), a self-limited infection that affects ganglia and their areas of innervation, producing severe neuralgic pain and vesicles on the skin.

Entry Terms : "Zoster Detection/Identification Reagents" , "Zoster (Varicella-Zoster) Virus Reagents, Identification" , "VZV (Varicella-Zoster Virus) Detection/Identification Reagents" , "Varicella-Zoster Virus (VZV) Detection/Identification Reagents" , "Varicella-Zoster Reagents, Identification" , "Varicella-Zoster Detection/Identification Reagents" , "Varicella (Chickenpox) Virus Reagents, Identification" , "Herpes Zoster Virus Detection/Identification Reagents" , "Chickenpox Virus Determination Reagents" , "Chickenpox (Varicella-Zoster) Virus Reagents, Identification" , "B568 Shingles Virus Detection/Identification Reagents" , "Reagents, Molecular Assay, Infection, Virus, Varicella-Zoster"

UMDC code : 19250

U.S.companies only
Suppress Subsidiary Companies

1-5 of 5 Match(es).

Alere Inc

Company Type: Parent

Alere Inc., a global healthcare company, announced a new partnership with Population Services International as part of the "Make (+) Positive More Positive Campaign.


Company Type: Parent

Mayo Medical Laboratories

Company Type: Parent

ZeptoMetrix Corp

Company Type: Parent

ZeptoMetrix is a privately held company formed in 1999 to serve the diagnostic and pharmaceutical research products industries. In 2003, the company acquired the BioClinical Partners division of Impath Corporation and a highly complementary and successful partnership was formed.

Zeus Scientific Inc

Company Type: Parent

ZEUS Scientific is a privately held corporation that was founded in 1976. The company began producing IFA (immunofluorescence assay) test systems followed ELISA and now multiplex (AtheNA Multi-Lyte) immunoassays. New products are developed to expand the menu which allows laboratories to run an increasing number of assays with common protocols and common reagents, as well as developing new tests to more accurately diagnose patients. In 1987 ZEUS Scientific was the first company to develop, receive appropriate regulatory clearance and bring to market a serological assay to test for Lyme disease – a condition with high prevalence in the local community where ZEUS Scientific is located.

1-5 of 5 Match(es).


Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs
Medical Product Guide Cancer Therapy Advisor Product Zone